243 studies found for:    Nanoparticles
Show Display Options
Rank Status Study
1 Recruiting Presence of Nanoparticles in the Amniotic Fluid
Condition: Intrauterine Disorder
Intervention: Procedure: Nanoparticles load
2 Active, not recruiting Addition of Silver Nanoparticles to a Orthodontic Primer in Preventing Enamel Demineralization Adjacent Brackets
Condition: Tooth Demineralization
Interventions: Other: Silver nanoparticles;   Other: Placebo
3 Completed Topical Application of Silver Nanoparticles and Oral Pathogens in Ill Patients
Condition: Critical Illness
Interventions: Other: silver nanoparticles;   Other: placebo
4 Unknown  Clinical Study on the Harvesting Lymph Nodes With Carbon Nanoparticles for Advanced Gastric Cancer
Condition: Advanced Gastric Cancer
Interventions: Drug: Carbon Nanoparticles;   Procedure: Gastrectomy with D2 dissection
5 Withdrawn C-VISA BikDD: Liposome in Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Genetic: BikDD Nanoparticle
6 Unknown  Fluor Varnish With Silver Nanoparticles for Dental Remineralization in Patients With Trisomy 21
Condition: Down Syndrome
Interventions: Drug: Fluor varnish;   Drug: Fluor varnish with nanoparticles
7 Unknown  Pilot Study - Putative Penetration of Nanoparticles in Sunscreen in Intact or Sunburned Skin
Conditions: Healthy Skin;   Sunburned Skin;   Titanium Dioxide;   Nanoparticles;   Penetrate Skin
8 Unknown  Capsaicin Nanoparticle in Patient With Painful Diabetic Neuropathy
Condition: Painful Diabetic Neuropathy
Interventions: Drug: 0.75% capsaicin nanoparticle cream;   Drug: Placebo
9 Unknown  Antibacterial Properties of Silicon Incorporated With Quaternary Ammonium Polyethylenimine Nanoparticles
Condition: Carcinoma of Head and Neck
Intervention: Device: polyethylenimine (PEI) nanoparticles.
10 Completed Potential Role for Carbon Nanoparticles to Guide Central Neck Dissection in Patients With Papillary Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Drug: carbon nanoparticles
11 Active, not recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer
Conditions: Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer;   Estrogen Receptor-negative Breast Cancer;   Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   HER2-positive Breast Cancer;   Progesterone Receptor-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Triple-negative Breast Cancer
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Other: questionnaire administration
12 Completed
Has Results
Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis
Condition: Coronary Restenosis
Intervention: Drug: Nanoparticle Paclitaxel
13 Unknown  Magnetic Nanoparticle Thermoablation-Retention and Maintenance in the Prostate:A Phase 0 Study in Men
Condition: Prostate Cancer
Intervention: Other: Magnetic Nanoparticle Injection
14 Recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer
Conditions: Recurrent Non-Small Cell Lung Carcinoma;   Stage IV Non-Small Cell Lung Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel Albumin-Stabilized Nanoparticle Formulation
15 Recruiting Selinexor, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Pancreatic Cancer
Conditions: Acinar Cell Adenocarcinoma of the Pancreas;   Duct Cell Adenocarcinoma of the Pancreas;   Stage IV Pancreatic Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Drug: selinexor;   Other: pharmacological study;   Other: laboratory biomarker analysis
16 Not yet recruiting Effect of Different Mouthrinses in Plaque Formation
Condition: Dental Plaque
Interventions: Drug: Chlorhexidine gluconate 0.12% (PerioGard®);   Drug: Nanoparticle solution of M. alternifolia oil (0.3%).
17 Recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery
Conditions: Pancreatic Acinar Cell Carcinoma;   Pancreatic Ductal Adenocarcinoma;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer
Interventions: Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel Albumin-Stabilized Nanoparticle Formulation;   Other: Pharmacological Study;   Other: Placebo;   Drug: WEE1 Inhibitor AZD1775
18 Active, not recruiting Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity
Conditions: Ovarian Cancer;   Peritoneal Cavity Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Other: liquid chromatography;   Other: mass spectrometry;   Other: pharmacological study;   Other: laboratory biomarker analysis
19 Unknown  The Differential Pattern of Deposition of Nano Particles in the Airways of Exposed Workers
Condition: Inadequate or Impaired Respiratory Function
20 Recruiting Nanoparticles in Nasal Mucosa
Conditions: Chronic Hypertrophic Rhinosinusitis;   Chronic Polypous Rhinosinusitis
Intervention: Procedure: Mucotomy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years